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Efficiency of probiotic autosymbions association {A. viridans and B. subtilis 3 strains) research
Introduction, Range of indications, covered using of probiotics is well 
- spread: in order to stimulate cellular and humoral factors of immunity'
activates of metabolism and normalize digestion, treatment and prevention of dysbiosis, integtinal infectious 
diseases and nutritional etiology'
normalization of digestive tract microflora after treatment with aniibiotics and other antibacterial remedies. This range 
of probiotics application in
the clinical practice would be significantly extended an antimicrobial therapy of the exterior purulent-inflammatory 
processesr'
probiotics couid contain both types of bacteria as well as monobiotics and associated strains several types of microorganisms 
(from-2 to
30) - associated probiotics. some types of probiotics have a vital importance in the humans, animals, birds, fish vital activities, i' e' wouldnt
depend on an organism of a.Jp.i-".y..id"nce, whe." these probiotics strains were selected, a so 
- called heterobiotics' Mostly, common
useage have the so - called homobiotics, carried out from biol,ogical material of the given type of animal or 
human organism' Recently in
medical practice autobiotics were proviclecl, carried out from theiormal strains of miiroflora, which 
should be isolated from an individual
organism, in order to correct its microecology' r - - --,--r ^--^:-^ ^ r--^Li^+:^. -^ri 
'
The autoprobiotic remedies composition advantages would be focused on several strains ofprobiotics, which 
properties complement each
other, souldnt carried out mutual antagonism3'
primary importance have been shJwn autoprobiotic remedies composition, which covered physiological, biochemical, 
antagonistic and
other properties. Finaly, interaction research between these probiotic associations hould affect into 
the remedies properties'
Aerococcus - .urri"a o,.ri from n-ormal microflora of hrrm"ns and animals, having a well 
- spread antagonistic actiona' Antagonistic
properties ofaerococcus souldbe connected for a long time with hydrogen peroxide 
- basic issue ofan industrial aerococcus train production'
as well as a final product .A - bacteriri' - which have been carried out in Microbiology, virology, Immunology 
and Epidemiology Department
at the SE 'Dnipropetrovsk Medical Academy MHU"5'
A series ofexperiments in vitro carriedout in order to research spectrum ofantagonistic action.A. vir.idans 
167 andclinical research of
.A 
- bacterin, have been shown a high inhibitory activity this type otbacteria towards nosocomial infections sources 
and microorganisms'
involved in the pathological microflora formation in a human intestine6'
l KapnronM.M.,rlpo6uoruxuraKKoMroHeHrepaAr{Kar{r'oH'orrrepanr{uq3BeHHorl6oresHra/M.M.Kapuuon,A.A.fxy6oe,3'3'caaton(racrpocec'tl
Z4-2Snox6pn20tt r.yllfacrpoelrrepooortt C""*r-lterep6ypra. - 201f. - iln +' 
- Mt:'; Koppexgut'guc6norttqecKtrxHapyuenuftnprl ea6oleraHl4'xxelyAotlHo
- Kn,oe.orororpa*ru, rr""""" i"ii;;;.;;-rrr*" go6uu.*" cupo6rorrvecrrrvrgericrareu/cororr,esaH,B., 
/Ierixtep c.H'' Eaxyrola T'A' (rgp')//
o6sopunox.nurrltvecrof$apuaxorror'{I4xne(aPcTBeHHoIiTepanrrI,t._jotl'_r.s.-.c.48-57.;IIase6HurII'E.,IIpur',reuerruenpo6nourro
,rerreHr{r,r 6ornurx AyoAe'anb'ori AsBoit, acco\n rpouuo"oii c Hp/rI. D. rase6nrn M. H. Pycra.uor//Xfi cD".A Harr. o6-ra rac:rpoentepolorou 
Pocclor
<KIaccr,r.IecKa'J,rup'IKnaAHit'racTPo3uTePo'orr'>:Te3'AoK,I.|-2uapta20|2t,M-2912]-C.19-20.;CaQorrooaM.A.I,1cnom,soBaHI{eKoMIUIeKca
6u<puno6arrepr,rft 
" 
na*ro6aqrzrrz i *opp"xqrr" g"c6axrepuoson/M.i. catfonooa, o. Io' Kysuerlon//Mexgynapo4' xou<p' 
<Euonot'a - HayKaXXI nera>: reg' -
M., 2012. - c. gl7 - gi8.; probiotics foitire preventior, *d rr"ut-"rrt of Antibiotic 
- Associated Diarrhea: A systematic Rwiew and Meta - analysisProbiotics for
Antibiotic - Associated piarrtrea/iusanne Hempel, sydne J. Newberry Alicia R. Maher ( et al.)//lAMA. 
- 2012. - vol. 307, Ne 18' - P' 1959-1969'
2 Ayronpo6ro,ruKr,r KaK cpeAcrBo npo{urarrrM rn<fenqnouno-rocflattrlTe/IbHblx ga6oaesa''{Ia y 
qe[oBeKa B r'{cKyccrBeHHoft cPeAe
o6"rarr"r/S. K. Izlnnrau, A. H. Cyeopor, H. B. i"po"""" (u 4p.)//Becrnrr PAMH' - 2013' - Ns 2' 
- C' 56-62'
3 sonneburg I. L. Genomic and metabolic studies ofthe impact ofprobiotics on a model gut symbiont 
and hosuJ' L. sonneburg' c' T. L. chen, f' I' Gordon//
PloSBiology. - 2006. - Vol. 4, Issue 12. - P.2273-2226'
4 A-6a*".pn" B ,reqe'r,rr{ u npoQlrnaxrnre ruortno-eocna.[r4renb'blx flpoqeccos/r' H. Kper"Ieu'ryqxrft, c' A' Prrxesxo' Io' /I' Bonrncxuft 
(u gp')' -
,{neuponerporcx, 2000. - 150 c.
5 puxeNxo C. A, Anrarouictu.rHa ar'aeuic* upo6iornxie y nignourenui uixpoopranieMis/C. A. Prxeuro//Ananra 
Me'rl.ltKosclroro iE-ry' - 2005' - Ne I '
eenpnrsi nonwqtrii Aerococcus viridans/C. A. Pnxenro, C. A. Yepnxel, C.I' KpeMeH'ryldbKvli//
4 EUROPEAN APPLIED SCIENCES
Research of the liquid forms
metabolism) and Bacillus subtilis
should have a vital importance.
Materials and methods. In accordance with methodt have been carried out allocation and identification of autostrain A. viridans in the
experimental animals.
In an experimental research liquid association carried out from probiotic complex of autostrains A. viridans (a) Ne 1 and industrial
strain B. subtilis 3 in order to microbioiogical background an exterior purulent-inflammatory processes antimicrobial therapy model:
staphylococcal infection, is carried out on white mice and burns and wounds treatment, caused by Pseudomonas aeruginosa, should be
appointed on the rats.
Modeling of staphylococcal infection in white mice was carried out by injectir.rg 0,1 ml 1 billion suspension of S. aureus daIly culture,
isolated from a patient with purulent discharge, subcutaneously. This model should obtain distinct symptoms of inflammation, developed in
mice in 2-3 days after infecti,on and continued 10-13 days. Staphylococcus, apPointed percutaneously, whould intensively growth caused local
manifestations of these disease.
In order to research ability ofprobiotic complex autostrain A. viridans (a) Ne 1 and industrial strain B. subtilis 3 ("PK"), carried out before
exposure of Staphylococcus ubcutaneously dose (1 ml 1 billion suspension) should appointed to 35 white mice in different terms as well as
before and aftei Siaphylococcus 0,1 ml "pK" (2 billion cells per one puspension). Control group covered l0 mice. observed time focused on
the local symptoms of the disease and an intensity of their development.
Experimental model of burns, infected with Ps eudomonas aeruginosa animals, provided under general anesthesia with thiopental sodium,
after that should be injured demaged side of animals as well as metal ring (diameter 2 cm) with a cotton swab dipped in alcohol and set on
fire. Wound was dried with a sterile swab and an infected (1 m1 10'gcells) dose of P. aeruginosa carried out into the center of a burn' waiting
the full absorption.
Action ofaerococcus and bacillus probiotic association were conducted on 44 rats, i. e. 20 animals was included in an experimental group
andz4 - to control group. In the expirimental group infected wounds of animals were treated daily, applying "PK" (2 billion in I ml) under
recovery. "pK" was alptea as well as the instillation on wound surface (exposure time 2 minutes). Wounds' surface in the control group of
animals was treated with isotonic sodium chloride same way, every day, carried out same exposure time. Observed period should be provided
3 weeks. Indicators of "pK" action are the following: intensity of the inflammation manifestations, terms of death or healing the wound surface.
ln order to research effect different doses of associated remedies, covered bacilli and aerococcus, through peroral way of transfer into
digestive tract of mice mucous membrane should be appointed non -physiological large doses (10 billion and 5 billion once a day for 10 days
"per os" to the mice, CBA type), as well as repeated each 2 months application 1 x 10e microbial cells.
For statistical analysis used solirvare package Statistica v6.1". Quantitative indicators should be presented as meaning with its standard error
(Mtm). Comparison an average meaning of these values was provided through criteria Student (t), relative values - Chi - square Pearson
(xr). Statistically significant differences whould be carried out whlle value p<0,05.
' 
Results and diicussion. Analysis of the results as well as impact PK in the model of Staphylococcus infection have been shown such terms
ofremedies intake: 5 hours earlier carrieed out for Staphylococcus, in 5 minutes and 5 hours after Staphyiococcus application, which contributes
antagonistic efect and prevents development of inliltration. Appiication of "PK" in a dose 0.I ml 2 billion daily probiotic culture association in
24 and 4g hours, should reduce manifeitations ofthe disease. In these cases, since 3-4 days, local process at experimental mice was significantly
diminished in contrast to control group ofanimals, where well-defined infiltration carried out 8 days ofobservation period (table 1' frg. 1,2)'
Fig. 1. Action of "PK" in a dose 2,0x10e cel ls in the
experimental group of animals, 4 day of observation
of nrobiotic association was carried out ou the basis of autostrain Aerococcus viridans (microaerophilous
: GVfTAV 105) - aerobic metabolism), as well as normal human microflora strains, in our point of view,
Fig. 2. Wound surface in the control
group of animals, 4 day of observation
Result of bacteriological examination purulent inflammation have been showed in the groups of mice, which were injected with associated
complex, along with disappearance local symptoms of inflammation should decrease Staphylococcus amount, taken from the abscess.
Staphylococcus disappeared on the 7s day. In the control group staphylococci whould visualise on I I days ofobservation.
(ra iu.)/iBiomedical Biosocial Anthropology. - 2006. - N 6. - P. 79-82.; Kpeueuqyr.{Kr4ri L H. Enonoflrqecxne cnoicrsa aePoKoKKoB-aHraroHI4croB-
upe4crarrrelert nnxpo6noqeuosos .rerronera/l'. H. KpeueHry{xvtilM. ll.Iop6yaona, /1. r. Ioprenr//Mrxpo6roa. xyPHan. - L994. - Ns 4(56). - C' 36-42.:
pnxenxo C. A. Kopexqix *rirpo6ioq,eHo3y Kr{ueqHnry npo6iorrxon A - 6axrepnu y xBopxx Ha grs6axrepios/C. A. Prxesro//MeAllqni rePcneKruBl4. -
"PK" injected subcutaneously Animals
amount
Appearance and intensity of inflammation (day)
I 2 3 4 7 8 9 l 0 1 t
a) in 5 hours befor
Staphvlococcus ini ection
5
b) in 5 hours and 3 hours befor
Staohvlococcus iniection
a) in 5 minutes after
Staphylococcus iniection
5
b) in 5 minutes and 3 hours
after
Staohvlococcus iniection
5
c) in an hour and 5 hours after
Staphvlococcus ini ection
5
d) in 24 hours after
Staohvlococcus iniection 5
++++ +++ T T i T i T ++ +
e) in 48 hours after
Staohvlococcus ini ection
5 ++++ ++++ +++ +++ T T T T +
control animals 10 ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ +++ ++ +
Table 1. - Development of local inf lammatory process in white mice towards exposit ion period and combinations
Staphylococcus and "PK" subcutaneous inject ion
Notes: "-" inflammation symptoms are absent; "+" - subtle hyperemia; mild hyperemia ancl edema; "+++" - during autopsy
carried out pyon; swelling und t.dn.5; "++++" - redness and swelling spread over a large area ofskin, during autopsy - mostly pyon.
Action ofaerococcus and bacillus probiotic association was evaluated in another model as well as Pseudomonas aeruginosa infection,
carried out on the rats with severe inflammation local manifestations of the pathological process. Results have been shown Protective efect
towards conrplex A. viriilans (a) Ne I and B. sutilis 3 at the daily application, carried out once per day under period of recover.
perifocal inflammation should be less significant by its intensity in the experimental gr0up of animals. On the other hand, wounds were
quickly released from pyon and covered with a dry scab (Fig. 3). Wounds at 60,0Vo f rats in the experimental group were completely bealed
with rejection of scab before I l,h day of observation. In the control group of animals similar pattern was observed only in 25,070 of cases
(x'=5,5; p<0,05) (Fig. a)'
' '  
* l
Fig. 3. Wound surface in the experimental group of animals,
treated with "PK" in a dose 2,0.10e cells, 7 day of observation
Fig. 4. Wound surface in the control group
of animals, 7day of observation
Amount of p, aeruginosa contained in a discharge from wounds oftreated rats, since remedy injection was on the lowest level than in the
control group (table 2). Among those animals, who were treated with probiotic complex, P aeruginosa contamination of wounds was below a
critical levelin a 4 day oftreatment, i. e. in 14 day the pathogen from wounds shouldrit sown. In the controi group tendency to clean wounds
was less significant. Reducing of seeding below a critical level should be carried out in a 7 day. On a 14 day microbial cleaning of animals
wounds shouldnt observed.
Dav of observation Experimental qroup Control sroup
1 ) 3
4,6+0,ix106 4,5+0,6x 105
z 4,0+0,6x 106 3,6+0,4x10o
Table 2. - Pseudomonas eruginosa cells per 1 ml, could been sown from the rats wounds (Mtm, n=10)
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I 2 J
5 3,5+0, lx 103 4,3+0,4x105 t
6 1,910,5x 10 3 4 ,8+0,3x10r
7 7,8+0,3x10, 6 ,5+0,1x  103
8 4,5+0,1x10'? 6,7+0,6x703
9 2,310,1x10 ' 5 ,5+0,2x10r
l 0 1,5+0,4x10'? 5,7+0,5x103
I ] 94x14 8,5+0,4x10'z
12 37+15 5,3+0,3x102
I J 8+4 1 , 5 + 0 , 1 x 1 0 ' z t
t4 0,2 t0 ,1x10 'z*
Note. * - p<0,001 in comparison with control group
Results ofan experiment have been shown, that in 100/o cases, carried out after treatment with probiotic complex, aerococcus and bacillus
from wounds should appear in 7 days after research remedy application'
In the histological pieparations was shown dynamics of changes mucous membrane in the digestive tract after l, 5, 10 and 30 days of the
suspension selected strain final application.
Research of sections, taken fiom an intestine of mice, carried out with electron microscopy, couldnt found any di-fferences towards
mucosa in the experimental and control group of mice. Finaly, biological associationA. viridans (k) and (z) shouldnt have antagonistic activity,
focused on the museum strain A. yiridans toz anacould be provided in order to prepare associated probiotic complexes B' sutilis 3.
Conclusions. Research protective action towards liquid probiotic mixture, have been selected from autostrain A. viridans (a) Ns 1 and B'
srbfiljs 3 (autoprobiotic complex), carried out in.the experimental models as well as external inflammatory processes, caused by Staphylococcus
andpseudominas aeruginoia,have been shown its effectiveness, probably, correspond to the probiotic proPerties due to synergistic effect.
probiotic complexihould be appointed in a dose 0.1 ml 2 billion ofthe daily probiotic culture association in 24 and 48 hours, reduced
manifestations of the disease. In these case, since 3-4 days localization process in experimental group of mice was signilicantly diminished in
contrast with control group of animals, where well-defined infiltration should persiste untill 8 days of observation.
Artificial *uy pri o, probiotic complex injection in a dose 5 billion cells per 10 days couldnt show any effects towards an intestinal
microflora in the experimental group of animals.
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